Approval of drug marketed to African Americans raises political, economic issues. Study criticizes manufacturer for re-branding generic drug with race-specific indication.
D001741:Black or African American; D017277:Drug Approval; D004338:Drug Combinations; D004345:Drug Industry; D004467:Economics; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D040541:Marketing / Q000379:methods*; D011057:Politics; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; C431665:isosorbide-hydralazine combination; D006830:Hydralazine; D007548:Isosorbide Dinitrate